Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS
· Delayed Price · Currency is USD
31.37
+1.47 (4.92%)
Mar 31, 2025, 4:00 PM EST
TKPHF Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Market Capitalization | 46,189 | 43,399 | 50,869 | 44,662 | 56,329 | 47,893 | Upgrade
|
| Market Cap Growth | -6.57% | -14.68% | 13.90% | -20.71% | 17.61% | -24.50% | Upgrade
|
| Enterprise Value | 79,262 | 75,918 | 81,755 | 74,563 | 98,218 | 94,787 | Upgrade
|
| Last Close Price | 31.37 | 27.76 | 31.94 | 28.73 | 35.67 | 29.36 | Upgrade
|
| PE Ratio | 34.90 | 45.57 | 21.33 | 23.57 | 16.57 | 116.48 | Upgrade
|
| PS Ratio | 1.45 | 1.54 | 1.68 | 1.52 | 1.95 | 1.57 | Upgrade
|
| PB Ratio | 0.89 | 0.90 | 1.06 | 0.95 | 1.20 | 1.09 | Upgrade
|
| P/FCF Ratio | 7.23 | 12.14 | 8.08 | 5.42 | 6.92 | 9.50 | Upgrade
|
| P/OCF Ratio | 5.95 | 9.16 | 6.92 | 4.83 | 6.16 | 7.69 | Upgrade
|
| EV/Sales Ratio | 2.58 | 2.69 | 2.70 | 2.54 | 3.40 | 3.10 | Upgrade
|
| EV/EBITDA Ratio | 8.99 | 10.09 | 8.98 | 7.65 | 11.04 | 11.59 | Upgrade
|
| EV/EBIT Ratio | 20.05 | 23.28 | 17.54 | 15.09 | 25.62 | 34.38 | Upgrade
|
| EV/FCF Ratio | 13.59 | 21.23 | 12.99 | 9.06 | 12.07 | 18.80 | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.75 | 0.77 | 0.85 | 0.98 | 1.16 | Upgrade
|
| Debt / EBITDA Ratio | 4.13 | 4.60 | 3.86 | 4.07 | 5.16 | 6.21 | Upgrade
|
| Debt / FCF Ratio | 5.92 | 10.10 | 5.81 | 4.81 | 5.64 | 10.07 | Upgrade
|
| Asset Turnover | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | 0.25 | Upgrade
|
| Inventory Turnover | 1.31 | 1.30 | 1.36 | 1.40 | 1.34 | 1.33 | Upgrade
|
| Quick Ratio | 0.59 | 0.50 | 0.49 | 0.73 | 1.00 | 0.65 | Upgrade
|
| Current Ratio | 1.31 | 1.11 | 0.97 | 1.21 | 1.53 | 1.14 | Upgrade
|
| Return on Equity (ROE) | 2.94% | 2.12% | 5.27% | 4.24% | 7.60% | 0.89% | Upgrade
|
| Return on Assets (ROA) | 2.51% | 2.12% | 2.85% | 2.88% | 2.06% | 1.39% | Upgrade
|
| Return on Capital (ROIC) | 2.97% | 2.57% | 3.57% | 3.62% | 2.59% | 1.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.50% | 3.90% | 5.40% | 5.40% | 3.80% | 2.80% | Upgrade
|
| Earnings Yield | 2.87% | 2.20% | 4.69% | 4.24% | 6.04% | 0.86% | Upgrade
|
| FCF Yield | 12.63% | 8.24% | 12.37% | 18.44% | 14.44% | 10.53% | Upgrade
|
| Dividend Yield | 4.27% | 4.48% | 4.24% | 5.16% | 4.56% | 5.70% | Upgrade
|
| Payout Ratio | 145.09% | 199.34% | 88.14% | 123.30% | 75.36% | 638.73% | Upgrade
|
| Buyback Yield / Dilution | -1.17% | -0.67% | 0.46% | -0.23% | -0.47% | -61.98% | Upgrade
|
| Total Shareholder Return | 3.09% | 3.81% | 4.70% | 4.93% | 4.09% | -56.28% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.